Free Trial

BioVie (BIVI) News Today

BioVie logo
$2.15 +0.09 (+4.37%)
(As of 05:19 PM ET)
BioVie files to sell 7.71M shares of common stock for holders
BioVie says Parkinson’s Disease clinical trial is fully funded
BioVie Raises $3.24 Million in Direct Offering
BioVie 1.15M share registered direct offering priced at $2.83
BioVie Inc. stock logo
BioVie Inc. (NASDAQ:BIVI) Short Interest Update
BioVie Inc. (NASDAQ:BIVI - Get Free Report) saw a large drop in short interest in October. As of October 15th, there was short interest totalling 187,700 shares, a drop of 51.0% from the September 30th total of 383,100 shares. Based on an average daily trading volume, of 4,550,000 shares, the short-interest ratio is currently 0.0 days. Approximately 3.4% of the company's stock are sold short.
BioVie Announces $6 Million Stock Offering and Placement
BioVie 2.667M share registered direct offering priced at $2.25
BioVie Secures $6.66 Million Through Direct Offering
BioVie Announces Stock Offering and Private Placement
BioVie Inc. stock logo
Traders Buy Large Volume of Call Options on BioVie (NASDAQ:BIVI)
BioVie Inc. (NASDAQ:BIVI - Get Free Report) saw unusually large options trading on Monday. Stock traders acquired 2,043 call options on the company. This is an increase of approximately 2,661% compared to the average daily volume of 74 call options.
BioVie secures patent for terlipressin formulation
BioVie Inc. stock logo
BioVie Inc. (NASDAQ:BIVI) Sees Large Drop in Short Interest
BioVie Inc. (NASDAQ:BIVI - Get Free Report) saw a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 139,800 shares, a drop of 8.3% from the August 31st total of 152,400 shares. Approximately 3.7% of the company's stock are sold short. Based on an average trading volume of 147,700 shares, the short-interest ratio is currently 0.9 days.
BioVie Inc. Announces Closing of Public Offering
Crude Oil Gains Over 1%; BioVie Shares Plunge
BioVie Inc. stock logo
BioVie (NASDAQ:BIVI) Shares Up 1.4%
BioVie (NASDAQ:BIVI) Trading Up 1.4%
BioVie Inc. Announces Pricing of Public Offering
BioVie Inc. Announces Proposed Public Offering
BioVie secures funding for long COVID drug trial
BioVie Inc. Announces Reverse Stock Split
BIVI Jul 2024 0.500 put
Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVI and its competitors with MarketBeat's FREE daily newsletter.

Wall St. Icon: “If you wait on this, it will already be too late” (Ad)

If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.

Go here now to see my urgent warning

BIVI Media Mentions By Week

BIVI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIVI
News Sentiment

0.00

0.55

Average
Medical
News Sentiment

BIVI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIVI Articles
This Week

0

3

BIVI Articles
Average Week

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BIVI) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners